ENERGY-GLOBE-FOUNDATION
1.12.2022 12:25:34 CET | Business Wire | Press release
In an extremely exciting ceremony on November 30 in Vienna at the world's most important environmental award, the world winners for sustainability were chosen in the 5 categories, Earth, Fire, Water, Air and Youth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005435/en/
From left to right - Freya Burton (LanzaTech – Winner Category AIR from China), Sarah Alexander (nurture.farm, AgTech Startup – Winner Category EARTH from India), Karl Boyce (ARC Power – Winner Category FIRE from Rwanda), Roberta Dixon-Valk (Take 3 for the Sea – Winner Category YOUTH from Australia), Rodrigo Oliveira (Eco Panplas – Winner Category WATER from Brazil) (Photo: Business Wire)
For more than 20 years, the Energy Globes have been awarded annually. In total, over 30,000 sustainable projects have been submitted, proposing innovative solutions to environmental problems. This was confirmed by high-ranking experts in a panel discussion before the ceremony, among them Nobel Laureate Prof. Mohan Munasinghe: “There is no shortage of solutions to our current crises, as the many projects entered for the Energy Globe have demonstrated impressively. It is important to inform people and economic players worldwide of these solutions, and to motivate them to join in their implementation.”
To achieve this, the unique www.checkpoint.eco portal providing advice on energy efficiency was introduced.
In the category “Earth”, projects from Ethiopia, Czech Republic and India were nominated, showing how vast areas of land can be made fertile again through reforestation, or replacing plastic-fillers with biological waste and fungi. The winner came from India, where a bio-enzyme prevented the burning off of millions of hectares of stubblefields and increased soil fertility at the same time.
The winning project in the “Fire” category came from Ruanda, where green electricity is being made available and affordable for everyone. The nominated projects from Portugal and Switzerland presented green electricity using sea wave power, and an energy saving of 90% for data storage in data centres, respectively.
A project from Brazil, which keeps 17 billion litres of drinking water clean annually through the collection and recycling of oil bottles, won the “Water” category. Runners-up from Slovenia and Jordan showed how filters in washing machines prevent microplastic fibres from getting into the wastewater, and how wastewater may be purified even in remote areas.
In the “Air” category, the winning project from China recycles CO2, thus manufacturing new fuels. Projects from Austria and Canada suggested ways of producing hydrogen independently and saving energy in air-condition systems while simultaneously improving air quality.
Winner in the ”Youth” category was a project from Australia, which is helping to educate young people in environmental matters in 129 countries.
At the end, a special prize for climate-friendly cooking, which affects billions of people, was awarded.
For details, see www.energyglobe.info
A new cryptocurrency for sustainability, SGCf (Sustainable Globe Coin fraction) for short, was also introduced for the first time. Thanks to a newly developed algorithm, production of the SGCf is energy-efficient, and the value of the currency is generated through zero-emission projects, resulting in financial incentives as well as investments in low-carbon, sustainable economic activities. The coin may be stored in digital wallets as well as converted into other currencies on www.xglober.com. Each Energy Globe World Award winner received EUR 3,000 Euro in SGCf.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005435/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
